US equities |
AAPL $331.93 ▼-1.89% MU $850.48 ▲+2.03% NVDA $207.87 ▲+2.87% AMD $491.40 ▲+5.26% SPCX $141.19 ▲+3.53% ORCL $127.22 ▲+6.71% PLTR $174.52 ▼-2.14% SNDK $1,110.79 ▲+3.32%
FinancialContent

Euda Health Holdings Limited - Ordinary Shares (NQ:EUDA)

15.65 +0.08 (+0.51%)
Delayed Quote Updated: 1:17 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Euda Health Holdings Limited - Ordinary Shares

News headline image
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Announces Reverse Stock Split of its Ordinary Shares
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Announces Second Amendment to Streeterville Warrant Agreement
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health to Launch EUDA Helixé 2.0 in January 2026
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Signs Letter of Intent to Potentially Acquire GO POSB
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
8i Acquisition 2 Corp. and EUDA Health Ltd Complete Business Combination
From EUDA Health Holdings Limited
Via GlobeNewswire